Journal of the National Cancer Institute. Monographs · 2017
US National Cancer Institute-China Collaborative Studies on Chinese Medicine and Cancer.
Письмо в редакциюНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jia Libin, Lin Hongsheng, Oppenheim Joost, Howard O M Zack, Li Jie, Fan Huiting, Zhao Zhizheng, Farrar William, Zhang Ying, Colburn Nancy, Young Matthew R, Li Weidong, Newman David, O'Keefe Barry R, Beutler John, Liu Jikai, Hao Xiaojiang, Yang Xiaosheng, Ji Tengfei, White Jeffrey D
Аннотация
Since 2007, the US National Cancer Institute (NCI) Office of Cancer Complementary and Alternative Medicine (OCCAM), together with the Cancer Institute of the China Academy of Chinese Medical Sciences (CICACMS), institutes at China Academy of Sciences and Chinese Academy of Medical Sciences, have engaged in collaborations on Chinese medicine (CM) and cancer research. Through these collaborations, CM drugs and compounds have been studied at NCI labs. This paper summarizes the discoveries and progress on these research projects, exploring the aspects of cancer prevention, botanical drug mechanisms of action and component analysis/quality control (QC), and anticancer activity screening. These and other related projects have been presented in various jointly convened workshops and have provided the backdrop for establishing a new organization, the International Consortium for CM and Cancer, to promote international collaborations in this field.